Stroke Treatment with Ancrod Trial "STAT"

Completed

Phase 3 Results

Summary of Purpose

To evaluate the safety and efficacy of ancrod in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Knoll Pharmaceutical, Mt. Olive, NJ

Trial Design

Randomized, parallel-group, double-blind, placebo-controlled study of 500 patients at 48 centers in the U.S. and Canada.

Contacts

  • David E. Levy, MD Knoll Pharmaceutical, Mt. Olive, NJ.

    sherman@uthscsa.edu